DIR Fees Archives | Frier Levitt

Master the Margin – Pharmacy Influencer Series: Trends in Reimbursement Solutions

Jesse C. Dresser, Esq. December 18, 2020

Frier Levitt Life Sciences Partner, Jesse C. Dresser, Esq. participated in a Master the Margin webinar with Ollin Sykes, CPA and Scotty Sykes, CPA, CFP® , both of Sykes & Company, P.A. to discuss recent trends in reimbursement... Read More

Provider Alert: Caremark Trimester 2 Reports of Year 2020 are now available

Brenna Sackman, Esq. and Steven L. Bennet, Esq. November 24, 2020

Pharmacy benefits manager (PBM) Caremark has now placed Trimester 2 reports for year 2020 in the Caremark Provider Portal. Caremark provides its summaries of Direct and Indirect Remuneration (DIR) Fees paid by pharmacy providers in these... Read More

Blogs & Articles | Community, Retail Pharmacies | DIR Fees | Life Sciences

PHARMACY ALERT: DIR Fee Performance Report Disputes Due Soon

Steven L. Bennet, Esq. and A.J. Barbarito, Esq. April 23, 2020

Pharmacies and dispensing physicians should be on the alert for performance reports issued by certain PBMs with regard to prescription adherence or patient satisfaction surveys for providers participating in Medicare performance networks. ... Read More

Blogs & Articles | DIR Fees | Pharmacy Law

Frier Levitt Alternative Fee Arrangements and Challenging DIR fees During COVID-19

Jonathan Levitt and Lucas W. Morgan, Esq. April 6, 2020

As COVID-19 grips the national economy, pharmacies are not immune from the financial fallout. Challenging PBMs’ abusive DIR fee recoupments is more important than ever to preserve the viability of independent pharmacy. As pharmacies struggle to... Read More

Blogs & Articles | Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law

Ohio Legislators Stand up to Predatory PBM Fees in 340B Drug Pricing Program

Sean E. Sanders, Esq., Marc V. Nocera, Esq. and Jesse C. Dresser, Esq. February 18, 2020

Ohio legislators have introduced bipartisan Senate and House bills aimed at curbing excessive fees charged by insurers and Pharmacy Benefit Managers to pharmacies and providers participating in the 340B Drug Pricing Program. The 340B Program,... Read More

Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law | Section 340B In-House and Contract Pharmacies

Pharmacy Benefit Managers Contribute to the Growing Rate of Independent Pharmacy Closures, However, Pharmacies Can Fight Back

Payal Amin, Pharm.D., RPh, Esq. and Jesse C. Dresser, Esq. February 17, 2020

As another independent pharmacy closed its doors last week in Connecticut, the owner of the pharmacy identified that the rising costs of operations and direct and indirect remuneration (DIR) fees along with the decreasing reimbursement rates each... Read More

What is Net Promoter Score and Why Should Your Pharmacy Care?

Steven L. Bennet, Esq. and Jonathan E. Levitt, Esq. February 10, 2020

Pharmacies and physicians that dispense should be aware of Net Promoter Scores (“NPS”). A NPS is a survey metric used by PBMs purportedly to evaluate customer or patient satisfaction. The score is calculated from responses to the question, such... Read More

Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law

PHARMACY ALERT: History and Status of Generic Effective Rate

Dae Y. Lee, Esq., Pharm.D CPBS February 7, 2020

We first reported in late 2018 that Pharmacy Benefit Managers (PBMs) and Pharmacy Services Administrative Organizations (PSAOs) have implemented a new type of post-sale recoupment called Generic Effective Rate (GER) upon their member pharmacies. In... Read More

Blogs & Articles | Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law

340B Contracting in an Age of DIR Fees and Predatory Pricing

Robert R. Granzen, Esq. September 3, 2019

The 340B program is a federal discount drug program which requires pharmaceutical manufacturers to enter into an agreement, called a Pharmaceutical Pricing Agreement (PPA), with the Secretary of the Department of Health & Human Services in... Read More

DIR Fees | Pharmacy Law | Section 340B In-House and Contract Pharmacies

Hot Topics in Specialty Pharmacy Law: PBM Prescription Trolling, HUB Arrangements, DIR Fees Update, Opioid and Naloxone Laws, and NADAC Pricing

Jesse C. Dresser, Esq. and Steven L. Bennet, Esq. June 9, 2017

Download the webinar slides. The specialty pharmacy industry has dramatically changed over the past few years and is now one of the fastest growing sources of revenue in the prescription drug marketplace. As a result, payers and PBMs... Read More

Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies

Category: DIR Fees